CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 120 enrolled
Drug / intervention
Dexmedetomidine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02878837
NCT02878837Phase 4Completed

Dex vs Dazzle: Dexmedetomidine vs Midazolam for Intraoperative Sedation

Instituto de Assistencia Medica ao Servidor Publico Estadual, Sao Paulo·interventional·Posted Aug 25, 2016·Updated Aug 22, 2017

In Brief

A Phase 4 clinical trial evaluating Dexmedetomidine and Midazolam for Failed Moderate Sedation During Procedure and Minimally Conscious State. Completed, enrolled 120 participants across 1 site.

Detailed Summary

This randomized, open clinical trial sought to compare the use of Midazolam and Dexmedetomidine during surgery in patients under regional anesthesia. The primary objective was to determine the superiority of either drug during the intraoperative period regarding: 1- Depth of sedation and 2- incidence of complications. Secondary objectives included the determination of superiority regarding the postoperative period. For that, patients were randomized into two groups and sedated with either Midazolam or Dexmedetomidine.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesBrazil
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 25, 2016
Enrollment StartJan 1, 2016
Primary CompletionApr 1, 2017
Study CompletionMay 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 9.9 years ago

Interventions

Dexmedetomidinedrug

Midazolamdrug